Buena Vista Regional Medical Center — Pricing
47 procedures published in this hospital's Machine-Readable File (MRF) — 47 with a comparable price, 0 with per-payer negotiated rates only. Prices shown are pre-insurance; actual cost depends on your plan, Medicare/Medicaid coverage, or cash-pay discounts.
Gross charges are the hospital's listed price — almost no one pays this amount. Your actual cost depends on your insurance plan. Use the cash price (when shown) as a guide for what uninsured patients are charged, and contact the hospital or your insurer for a personalized cost estimate.
Published charges
Showing all 47 procedures with a comparable published price (gross, cash, or insurance-negotiated median), sorted highest to lowest. Green = this hospital prices below the median; amber = above.
| DRG | Description | Published price | Cash price | vs. IA median | vs. National median | ||
|---|---|---|---|---|---|---|---|
| 483 | DRG MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $79,710 | $63,768 | $39,466 | +102% | $60,369 | +32% |
| 481 | DRG HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $45,571 | $36,456 | $35,042 | +30% | $57,107 | −20% |
| 617 | DRG AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | $36,109 | $28,887 | $70,707 | −49% | $42,881 | −16% |
| 854 | DRG INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | $34,982 | $27,985 | $39,406 | −11% | $44,357 | −21% |
| 470 | Major joint replacement or reattachment of lower extremity without major comorbid conditions or complications (MCC). | $33,207 | $26,565 | $58,965 | −44% | $51,133 | −35% |
| 378 | DRG G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $29,776 | $23,820 | $31,379 | −5% | $22,098 | +35% |
| 787 | DRG CESAREAN SECTION WITHOUT STERILIZATION WITH COMPLICATION OR COMORBIDITY (CC) | $27,196 | $21,756 | $19,959 | +36% | $23,571 | +15% |
| 070 | DRG NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $26,494 | $21,195 | $28,265 | −6% | $33,652 | −21% |
| 982 | DRG EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | $25,594 | $20,475 | $86,898 | −71% | $51,985 | −51% |
| 064 | DRG INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $25,078 | $20,062 | $27,049 | −7% | $39,106 | −36% |
| 189 | DRG PULMONARY EDEMA AND RESPIRATORY FAILURE - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $24,345 | $19,476 | $22,235 | +9% | $27,470 | −11% |
| 194 | DRG SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $24,289 | $19,431 | $17,866 | +36% | $18,961 | +28% |
| 884 | DRG ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | $21,050 | $16,840 | $70,133 | −70% | $27,002 | −22% |
| 788 | DRG CESAREAN SECTION WITHOUT STERILIZATION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $20,461 | $16,368 | $19,013 | +8% | $20,139 | +2% |
| 440 | DRG DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $18,413 | $14,730 | $16,323 | +13% | $15,907 | +16% |
| 689 | DRG KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $17,711 | $14,168 | $26,112 | −32% | $25,980 | −32% |
| 785 | DRG CESAREAN SECTION WITH STERILIZATION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $17,664 | $14,131 | $17,664 | +0% | $20,473 | −14% |
| 190 | DRG CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $13,641 | $10,912 | $22,170 | −38% | $24,930 | −45% |
| 885 | DRG PSYCHOSES - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $13,595 | $10,876 | $16,497 | −18% | $21,729 | −37% |
| 193 | DRG SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $13,501 | $10,800 | $23,467 | −42% | $29,171 | −54% |
| 092 | DRG OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | $12,806 | $10,244 | $28,168 | −55% | $24,914 | −49% |
| 057 | DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $12,695 | $10,156 | $18,497 | −31% | $27,621 | −54% |
| 558 | DRG TENDONITIS, MYOSITIS AND BURSITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $12,677 | $10,141 | $38,420 | −67% | $18,602 | −32% |
| 439 | DRG DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | $11,767 | $9,413 | $27,045 | −56% | $20,093 | −41% |
| 308 | DRG CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $11,322 | $9,057 | $29,298 | −61% | $26,770 | −58% |
| 393 | DRG OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $11,188 | $8,950 | $39,722 | −72% | $34,192 | −67% |
| 291 | DRG HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $9,229 | $7,383 | $19,371 | −52% | $27,864 | −67% |
| 177 | DRG RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $9,202 | $7,361 | $26,250 | −65% | $34,448 | −73% |
| 264 | ACETAMINOPHEN 10 MG/ML IV SOLN | $9,183 | $7,346 | $43,017 | −79% | $53,069 | −83% |
| 897 | DRG ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | $8,848 | $7,078 | $19,393 | −54% | $16,765 | −47% |
| 309 | DRG CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | $7,808 | $6,246 | $15,515 | −50% | $17,477 | −55% |
| 560 | DRG AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $7,781 | $6,224 | $15,845 | −51% | $25,279 | −69% |
| 880 | DRG ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION | $7,715 | $6,172 | $10,697 | −28% | $16,001 | −52% |
| 690 | DRG KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | $7,112 | $5,689 | $15,222 | −53% | $17,817 | −60% |
| 566 | DRG OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $6,693 | $5,354 | $9,216 | −27% | $14,716 | −55% |
| 872 | DRG SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $6,628 | $5,302 | $25,604 | −74% | $22,888 | −71% |
| 806 | DRG VAGINAL DELIVERY WITHOUT STERILIZATION/D&C WITH COMPLICATION OR COMORBIDITY (CC) | $6,524 | $5,219 | $10,947 | −40% | $13,652 | −52% |
| 807 | DRG VAGINAL DELIVERY WITHOUT STERILIZATION/D&C WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $4,967 | $3,973 | $10,333 | −52% | $12,551 | −60% |
| 390 | DRG G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $4,843 | $3,874 | $7,182 | −33% | $13,414 | −64% |
| 280 | DRG ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $4,609 | $3,687 | $17,434 | −74% | $32,530 | −86% |
| 781 | AMPICILLIN SODIUM 2 G IJ SOLR | $3,963 | $3,170 | $3,963 | — | $3,963 | +0% |
| 794 | DRG NEONATE WITH OTHER SIGNIFICANT PROBLEMS | $3,499 | $2,799 | $8,633 | −59% | $8,633 | −59% |
| 641 | ONDANSETRON HCL 4 MG/2ML IJ SOLN | $3,149 | $2,519 | $16,753 | −81% | $17,186 | −82% |
| 789 | DRG NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY | $2,819 | $2,255 | $4,646 | −39% | $18,632 | −85% |
| 338 | LACTATED RINGERS IV BOLUS | $2,161 | $1,728 | $10,586 | −80% | $30,138 | −93% |
| 795 | DRG NORMAL NEWBORN | $2,044 | $1,635 | $6,720 | −70% | $5,293 | −61% |
| 409 | KETOROLAC TROMETHAMINE 15 MG/ML IJ SOLN | $744 | $595 | $28,820 | −97% | $46,066 | −98% |